IQST Fundamental Analysis - IQSTEL INC

Name: IQSTEL INC (IQST) Stock
Brand: IQSTEL INC
Rating: 3.5 (3 reviews)

Fundamental Rating

Overall IQST gets a fundamental rating of 2 out of 10. We evaluated IQST against 36 industry peers in the Diversified Telecommunication Services industry. Both the profitability and financial health of IQST have multiple concerns. IQST is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IQST has reported negative net income.

In the past year IQST has reported a negative cash flow from operations.

IQST had negative earnings in each of the past 5 years.

IQST had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of IQST (-8.38%) is worse than 86.11% of its industry peers.

With a Return On Equity value of -91.71%, IQST is not doing good in the industry: 80.56% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-8.38%
ROE	-91.71%
ROIC	N/A

ROA(3y)-21.03%

ROA(5y)-43.18%

ROE(3y)-66.26%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IQST has a Gross Margin of 2.90%. This is amonst the worse of the industry: IQST underperforms 88.89% of its industry peers.

IQST's Gross Margin has declined in the last couple of years.

IQST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	2.9%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.29%

GM growth 5Y-7.56%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IQST does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for IQST has been increased compared to 1 year ago.

IQST has more shares outstanding than it did 5 years ago.

The debt/assets ratio for IQST is higher compared to a year ago.

2.2 Solvency

IQST has an Altman-Z score of 3.09. This indicates that IQST is financially healthy and has little risk of bankruptcy at the moment.

IQST has a better Altman-Z score (3.09) than 88.89% of its industry peers.

IQST has a Debt/Equity ratio of 0.68. This is a neutral value indicating IQST is somewhat dependend on debt financing.

The Debt to Equity ratio of IQST (0.68) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.68
Debt/FCF	N/A
Altman-Z	3.09

ROIC/WACCN/A

WACC10.32%

2.3 Liquidity

A Current Ratio of 0.99 indicates that IQST may have some problems paying its short term obligations.

With a Current ratio value of 0.99, IQST is not doing good in the industry: 61.11% of the companies in the same industry are doing better.

A Quick Ratio of 0.99 indicates that IQST may have some problems paying its short term obligations.

The Quick ratio of IQST (0.99) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	0.99
Quick Ratio	0.99

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IQST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -291.78%.

Looking at the last year, IQST shows a very strong growth in Revenue. The Revenue has grown by 95.96%.

Measured over the past years, IQST shows a very strong growth in Revenue. The Revenue has been growing by 73.47% on average per year.

EPS 1Y (TTM)-291.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-2300%

Revenue 1Y (TTM)95.96%

Revenue growth 3Y63.58%

Revenue growth 5Y73.47%

Sales Q2Q%109.24%

3.2 Future

IQST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.10% yearly.

IQST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.26% yearly.

EPS Next Y41.97%

EPS Next 2Y36.87%

EPS Next 3Y25.1%

EPS Next 5YN/A

Revenue Next Year21.05%

Revenue Next 2Y21.18%

Revenue Next 3Y17.26%

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IQST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IQST. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

IQST's earnings are expected to grow with 25.10% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y36.87%

EPS Next 3Y25.1%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IQST!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IQSTEL INC

NASDAQ:IQST (11/21/2025, 3:45:16 PM)

4.32

+0.2 (+4.85%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupTelecommunication Services

GICS IndustryDiversified Telecommunication Services

Earnings (Last)11-06 2025-11-06

Earnings (Next)03-30 2026-03-30

Inst Owners3.94%

Inst Owner Change0%

Ins Owners0.89%

Ins Owner Change0%

Market Cap15.60M

Revenue(TTM)283.17M

Net Income(TTM)-6.62M

Analysts82.86

Price Target18.36 (325%)

Short Float %4%

Short Ratio1.27

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-24.06%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.94%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.06
P/FCF	N/A
P/OCF	N/A
P/B	2.16
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-2.86

EYN/A

EPS(NY)-1.68

Fwd EYN/A

FCF(TTM)-0.85

FCFYN/A

OCF(TTM)-0.81

OCFYN/A

SpS78.44

BVpS2

TBVpS-1.93

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.38%
ROE	-91.71%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	2.9%
FCFM	N/A

ROA(3y)-21.03%

ROA(5y)-43.18%

ROE(3y)-66.26%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.29%

GM growth 5Y-7.56%

F-Score1

Asset Turnover3.58

Health

		Industry Rank	Sector Rank
Debt/Equity	0.68
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	30.35%
Cap/Sales	0.05%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.99
Quick Ratio	0.99
Altman-Z	3.09

F-Score1

WACC10.32%

ROIC/WACCN/A

Cap/Depr(3y)97.68%

Cap/Depr(5y)135.43%

Cap/Sales(3y)0.11%

Cap/Sales(5y)0.18%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-291.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-2300%

EPS Next Y41.97%

EPS Next 2Y36.87%

EPS Next 3Y25.1%

EPS Next 5YN/A

Revenue 1Y (TTM)95.96%

Revenue growth 3Y63.58%

Revenue growth 5Y73.47%

Sales Q2Q%109.24%

Revenue Next Year21.05%

Revenue Next 2Y21.18%

Revenue Next 3Y17.26%

Revenue Next 5YN/A

EBIT growth 1Y-844.69%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year511.99%

EBIT Next 3Y152.86%

EBIT Next 5YN/A

FCF growth 1Y-80.87%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-97.49%

OCF growth 3YN/A

OCF growth 5YN/A

IQSTEL INC / IQST FAQ

What is the fundamental rating for IQST stock?

ChartMill assigns a fundamental rating of 2 / 10 to IQST.

Can you provide the valuation status for IQSTEL INC?

ChartMill assigns a valuation rating of 1 / 10 to IQSTEL INC (IQST). This can be considered as Overvalued.

How profitable is IQSTEL INC (IQST) stock?

IQSTEL INC (IQST) has a profitability rating of 0 / 10.

How financially healthy is IQSTEL INC?

The financial health rating of IQSTEL INC (IQST) is 2 / 10.

IQSTEL INC (IQST) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

IQSTEL INC / IQST FAQ

What is the fundamental rating for IQST stock?

Can you provide the valuation status for IQSTEL INC?

How profitable is IQSTEL INC (IQST) stock?

How financially healthy is IQSTEL INC?